Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Three Different Final Irrigants and Showing Their Effects on the Success of Revascularization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03591172
Recruitment Status : Unknown
Verified May 2018 by Maha Ahmed Nassar, Cairo University.
Recruitment status was:  Not yet recruiting
First Posted : July 19, 2018
Last Update Posted : July 19, 2018
Sponsor:
Information provided by (Responsible Party):
Maha Ahmed Nassar, Cairo University

Brief Summary:
this study will assess different irrigating materials on the success revascularization of necrotic mature teeth associated with PRF.

Condition or disease Intervention/treatment Phase
Post-operative Pain Drug: Propolis Drug: Nano-propolis Drug: saline Not Applicable

Detailed Description:
Nano-propolis and Propolis will be used as final endodontic irrigants and will be compared to saline in Revascularization of necrotic mature teeth.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 75 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Other
Official Title: Assessment of Implementing Nano-technology in the Irrigation Protocol of One Step Revascularization For Necrotic Mature Teeth
Estimated Study Start Date : September 2018
Estimated Primary Completion Date : November 2018
Estimated Study Completion Date : September 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: propolis
natural antibacterial, anti-inflammatory irrigation solution
Drug: Propolis
Using propolis as a final irrigation in revascularization
Other Name: natural irrigant

Experimental: Nano-propolis
natural antibacterial, anti-inflammatory irrigation solution
Drug: Nano-propolis
Using Nano-propolis as a final irrigation in revasculariztion
Other Name: Natural irrigant

Active Comparator: saline
sodium chloride irrigation solution
Drug: saline
Using saline as a final irrigation in revasculariztion
Other Name: sodium chloride




Primary Outcome Measures :
  1. post-operative pain: Visual analogue scale [ Time Frame: 1 year ]
    post-operative pain evaluated using Visual analogue scale , 0 no pain, 10 severe pain.


Secondary Outcome Measures :
  1. periapical healing [ Time Frame: 1 year ]
    evaluated radiographically

  2. sensitivity [ Time Frame: 1 year ]
    electric pulp tester

  3. survival [ Time Frame: 1 year ]
    clinical evaluation



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 40 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • mature teeth.
  • teeth with periapical periodontitis.
  • Maxillary anterior teeth
  • Patients should be free from any systemic disease
  • Patients who will agree to the consent and will commit to follow-up period.

Exclusion Criteria:

  • Patients with immature roots.
  • Patients with any systemic disease that may affect normal healing.
  • Patients with swelling. .Pregnant females. .Patients who could/would not participate in a 1-year follow-up. .Patients with fistula. .Patients with old age. .Teeth with periodontal involvement. .Teeth with vertical root fractures. .Non-restorable teeth.
Layout table for additonal information
Responsible Party: Maha Ahmed Nassar, principal investigator, Cairo University
ClinicalTrials.gov Identifier: NCT03591172    
Other Study ID Numbers: CEBD_CU_2018_05_29
First Posted: July 19, 2018    Key Record Dates
Last Update Posted: July 19, 2018
Last Verified: May 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Neurologic Manifestations
Propolis
Anti-Infective Agents